Search

Your search keyword '"Fujimaru, T."' showing total 81 results

Search Constraints

Start Over You searched for: Author "Fujimaru, T." Remove constraint Author: "Fujimaru, T."
81 results on '"Fujimaru, T."'

Search Results

3. Kidney enlargement and multiple liver cyst formation implicate mutations inPKD1/2in adult sporadic polycystic kidney disease

4. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.

5. Magnetic Property of Electrodeposited Ni-W, Ni-Mo and Ni-Cr Alloys

6. Endoscopic resection of a large pedunculated colonic polyp using an insulated-tip diathermy knife

7. Soft Magnetic Property of Electrodeposited Nickel-Tungsten Alloys

11. Endoscopic resection with hypertonic saline-solution-epinephrine injection plus band ligation for large pedunculated or semipedunculated gastric polyp.

12. Jejunal stromal tumor

14. Systematic literature review of the diagnosis, prognosis, and treatment of peritoneal dialysis-related infection caused by nontuberculous mycobacteria.

15. Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.

16. Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

17. Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History.

18. Autosomal-dominant tubulointerstitial kidney disease with a novel UMOD mutation, overlapping with Sjogren's syndrome: a case report.

19. Cytomegalovirus Infection of the Gastrointestinal Tract in Patients on Hemodialysis: A Case Report and Literature Review.

20. Barriers to conservative kidney management for Japanese healthcare professionals involved in the treatment of end-stage renal disease.

21. Primary Cilia Elongation in Early-Onset Polycystic Kidney Disease with 2 Hypomorphic PKD1 Alleles: A Case Report.

22. CFAP47 is a novel causative gene implicated in X-linked polycystic kidney disease.

23. Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology.

24. Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

25. Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.

26. Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

27. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

28. Changes in Metabolomic Profiles Induced by Switching from an Erythropoiesis-Stimulating Agent to a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Hemodialysis Patients: A Pilot Study.

29. Different Clinical Courses of Nephronophthisis in Dizygotic Twins.

30. A case of systemic sarcoidosis with mesangial proliferative glomerulonephritis showing predominant deposition of IgG in the mesangial region.

31. Role of the new bioimpedance monitoring device (Seca ® ) in assessing dry weight in hemodialysis patients.

32. Efficacy of renin-angiotensin-aldosterone system blockades for acute phase hypertensive emergencies in patient complicating severe acute kidney injury.

33. Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease.

34. Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease.

35. Effect of in vitro growth on mouse oocyte competency, mitochondria and transcriptome.

36. Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD 2 in the kidney.

37. Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis.

38. Phenotypic differences of mutation-negative cases in Gitelman syndrome clinically diagnosed in adulthood.

39. A Novel LMX1B Variant Identified in a Patient Presenting with Severe Renal Involvement and Thin Glomerular Basement Membrane.

40. Association between chronic kidney disease and mortality in stage IV cancer.

42. Renal TNFα activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease.

43. Serial measurement of electrolyte and citrate concentrations in blood-primed continuous hemodialysis circuits during closed-circuit dialysis.

44. Development of acute kidney injury with massive granular casts and microscopic hematuria in patients with COVID-19: two case presentations with literature review.

45. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.

46. A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.

47. PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion.

48. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.

49. Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter.

50. Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter.

Catalog

Books, media, physical & digital resources